Cerebral small vessel disease-related protease HtrA1 processes latent TGF-β binding protein 1 and facilitates TGF-β signaling
Open accessThe DOI matches its Crossref record; 39 of the 40 references it cites were found in a registry or an index.
Abstract
Significance: Cerebral small vessel disease (SVD) is a major cause of stroke and dementia. Hereditary forms, such as cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy (CARASIL), may provide insights into key molecular mechanisms and pathways. The serine protease HtrA1, whose activity is impaired in CARASIL, has been proposed to attenuate TGF-β signaling leading to increased pathway activity in diseased arteries. We analyzed HtrA1-deficient mouse brain tissue and mouse and CARASIL patient fibroblasts and found a reduction in signaling activity on various pathway levels suggesting a facilitating role of HtrA1. Moreover, we identified LTBP-1 as a novel HtrA1 substrate and provide evidence for its functional modulation by HtrA1-dependent proteolysis. Our data suggest down-regulation of TGF-β signaling as a key mechanism underlying CARASIL pathogenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Another, less common arteriopathy associated with cognitive decline and dementia is cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy, a condition caused by HTRA1 mutations. 114,115”
From Vascular Cognitive Impairment (2017) · cites this paper as [115]
The cited source says what the claim attributes to it.
In the citing paper
“its encoded protein HTRA1 plays a key role in facilitating TGF𝛃 signaling through processing latent TGF𝛃 binding protein 1 (LTBP-1) (55).”
From Blood-Brain Barrier: From Physiology to Disease and Back (2019) · cites this paper as [55]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Extracellular Matrix: Not Just Pretty Fibrils
Hynes, R. O. (2009) · Science · doi:10.1126/science.1176009 · Cited by 3,527
Mechanisms of sporadic cerebral small vessel disease: insights from neuroimaging
Wardlaw, J. M., Smith, C., & Dichgans, M. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(13)70060-7 · Cited by 1,657 · cited 1×
“C small vessel disease (SVD) accounts for roughly one fifth of all strokes worldwide and is recognized as a major cause of cognitive decline and dementia (1).”
BackgroundSelf-citationChabriat, H., Joutel, A., Dichgans, M., Tournier-Lasserve, E., & Bousser, M.-G. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70127-9 · Cited by 1,088
Self-citationExtracellular control of TGFβ signalling in vascular development and disease
ten Dijke, P., & Arthur, H. M. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2262 · Cited by 778
TGF-β signaling in vascular biology and dysfunction
Goumans, M.-J., Liu, Z., & ten Dijke, P. (2009) · Cell Research · doi:10.1038/cr.2008.326 · Cited by 601
TGF-β signaling in vascular fibrosis
RUIZORTEGA, M., RODRIGUEZVITA, J., SANCHEZLOPEZ, E., CARVAJAL, G., & EGIDO, J. (2007) · Cardiovascular Research · doi:10.1016/j.cardiores.2007.02.008 · Cited by 492
HTRA proteases: regulated proteolysis in protein quality control
Clausen, T., Kaiser, M., Huber, R., & Ehrmann, M. (2011) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3065 · Cited by 478
Self-citationAssociation of HTRA1 Mutations and Familial Ischemic Cerebral Small-Vessel Disease
Hara, K., Shiga, A., Fukutake, T., Nozaki, H., Miyashita, A., Yokoseki, A., Kawata, H., Koyama, A., Arima, K., Takahashi, T., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0801560 · Cited by 460
Taipale, J., Miyazono, K., Heldin, C., & Keski-Oja, J. (1994) · The Journal of cell biology · doi:10.1083/jcb.124.1.171 · Cited by 448
Proteolysis of Latent Transforming Growth Factor-β (TGF-β)-binding Protein-1 by Osteoclasts
Dallas, S. L., Rosser, J. L., Mundy, G. R., & Bonewald, L. F. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111663200 · Cited by 414
Signaling by members of the TGF-β family in vascular morphogenesis and disease
Pardali, E., Goumans, M.-J., & ten Dijke, P. (2010) · Trends in Cell Biology · doi:10.1016/j.tcb.2010.06.006 · Cited by 401
Dichgans, M. (2007) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70028-5 · Cited by 397
Self-citationHtrA1 serine protease inhibits signaling mediated by Tgfβ family proteins
Oka, C., Tsujimoto, R., Kajikawa, M., Koshiba-Takeuchi, K., Ina, J., Yano, M., Tsuchiya, A., Ueta, Y., Soma, A., Kanda, H., et al. (2004) · Development · doi:10.1242/dev.00999 · Cited by 334
Dallas, S. L., Sivakumar, P., Jones, C. J. P., Chen, Q., Peters, D. M., Mosher, D. F., Humphries, M. J., & Kielty, C. M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m410762200 · Cited by 316
BMP1 controls TGFβ1 activation via cleavage of latent TGFβ-binding protein
Ge, G., & Greenspan, D. S. (2006) · The Journal of Cell Biology · doi:10.1083/jcb.200606058 · Cited by 275
Matrix control of transforming growth factor- function
Horiguchi, M., Ota, M., & Rifkin, D. B. (2012) · Journal of Biochemistry · doi:10.1093/jb/mvs089 · Cited by 258
Implications of the serine protease HtrA1 in amyloid precursor protein processing
Grau, S., Baldi, A., Bussani, R., Tian, X., Stefanescu, R., Przybylski, M., Richards, P., Jones, S. A., Shridhar, V., Clausen, T., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0501823102 · Cited by 215 · cited 2×
“Processing was abolished by the selective HtrA1 inhibitor NVP-LBG976 (10), but persisted in the presence of the metalloprotease inhibitor EDTA confirming the specificity of the cleavage (Fig.”
BackgroundSelf-citationThompson, C. S., & Hakim, A. M. (2009) · Stroke · doi:10.1161/strokeaha.108.542266 · Cited by 208
Zilberberg, L., Todorovic, V., Dabovic, B., Horiguchi, M., Couroussé, T., Sakai, L. Y., & Rifkin, D. B. (2012) · Journal of Cellular Physiology · doi:10.1002/jcp.24094 · Cited by 181 · cited 14×
“Immunofluorescence analysis confirmed the impaired association of the ΔC-A225-LTBP-1 variant with the ECM (Fig.”
BackgroundInfluentialFontana, L., Chen, Y., Prijatelj, P., Sakai, T., Fässler, R., Sakai, L. Y., & Rifkin, D. B. (2005) · The FASEB Journal · doi:10.1096/fj.05-4134com · Cited by 178
Tatti, O., Vehviläinen, P., Lehti, K., & Keski‐Oja, J. (2008) · Experimental Cell Research · doi:10.1016/j.yexcr.2008.05.018 · Cited by 176
Vierkotten, S., Muether, P. S., & Fauser, S. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022959 · Cited by 174
Fukutake, T. (2011) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2010.11.008 · Cited by 167
Jones, A., Kumar, S., Zhang, N., Tong, Z., Yang, J.-H., Watt, C., Anderson, J., Amrita, Fillerup, H., McCloskey, M., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1102853108 · Cited by 162
LTBPs, more than just an escort service
Todorovic, V., & Rifkin, D. B. (2012) · Journal of Cellular Biochemistry · doi:10.1002/jcb.23385 · Cited by 140
Matrix‐dependent perturbation of TGFβ signaling and disease
Doyle, J. J., Gerber, E. E., & Dietz, H. C. (2012) · FEBS Letters · doi:10.1016/j.febslet.2012.05.027 · Cited by 127
HtrA1-dependent proteolysis of TGF-β controls both neuronal maturation and developmental survival
Launay, S., Maubert, E., Lebeurrier, N., Tennstaedt, A., Campioni, M., Docagne, F., Gabriel, C., Dauphinot, L., Potier, M., Ehrmann, M., et al. (2008) · Cell Death and Differentiation · doi:10.1038/cdd.2008.82 · Cited by 118
Self-citationIdentification of Novel Substrates for the Serine Protease HTRA1 in the Human RPE Secretome
An, E., Sen, S., Park, S. K., Gordish-Dressman, H., & Hathout, Y. (2010) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.09-4853 · Cited by 117
Cerebral small-vessel disease protein HTRA1 controls the amount of TGF-β1 via cleavage of proTGF-β1
Shiga, A., Nozaki, H., Yokoseki, A., Nihonmatsu, M., Kawata, H., Kato, T., Koyama, A., Arima, K., Ikeda, M., Katada, S., et al. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr063 · Cited by 115
Highly sensitive and specific bioassay for measuring bioactive TGF-β
Tesseur, I., Zou, K., Berber, E., Zhang, H., & Wyss-Coray, T. (2006) · BMC Cell Biology · doi:10.1186/1471-2121-7-15 · Cited by 114
Joutel, A., & Faraci, F. M. (2014) · Stroke · doi:10.1161/strokeaha.113.002878 · Cited by 112
Unsöld, C., Hyytiäinen, M., Bruckner-Tuderman, L., & Keski-Oja, J. (2001) · Journal of Cell Science · doi:10.1242/jcs.114.1.187 · Cited by 104
Human High Temperature Requirement Serine Protease A1 (HTRA1) Degrades Tau Protein Aggregates
Tennstaedt, A., Pöpsel, S., Truebestein, L., Hauske, P., Brockmann, A., Schmidt, N., Irle, I., Sacca, B., Niemeyer, C. M., Brandt, R., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.316232 · Cited by 98
Self-citationGraham, J. R., Chamberland, A., Lin, Q., Li, X., Dai, D., Zeng, W., RYAN, M. S., Rivera-Bermudez, M. A., Flannery, C. R., & Yang, Z. (2013) · PLoS ONE · doi:10.1371/journal.pone.0074094 · Cited by 85
Hereditary cerebral small vessel diseases: a review
Federico, A., Di Donato, I., Bianchi, S., Di Palma, C., Taglia, I., & Dotti, M. T. (2012) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2012.07.041 · Cited by 82
The Emerging Roles of HTRA1 in Musculoskeletal Disease
Tiaden, A. N., & Richards, P. J. (2013) · American Journal Of Pathology · doi:10.1016/j.ajpath.2013.02.003 · Cited by 75
Sequestration of latent TGF-β binding protein 1 into CADASIL-related Notch3-ECD deposits
Kast, J., Hanecker, P., Beaufort, N., Giese, A., Joutel, A., Dichgans, M., Opherk, C., & Haffner, C. (2014) · Acta Neuropathologica Communications · doi:10.1186/s40478-014-0096-8 · Cited by 60
Self-citationA novel mutation in the HTRA1 gene causes CARASIL without alopecia
Nishimoto, Y., Shibata, M., Nihonmatsu, M., Nozaki, H., Shiga, A., Shirata, A., Yamane, K., Kosakai, A., Takahashi, K., Nishizawa, M., et al. (2011) · Neurology · doi:10.1212/wnl.0b013e318215281d · Cited by 46
Downregulation of Serine Protease HTRA1 Is Associated with Poor Survival in Breast Cancer
Lehner, A. V., Magdolen, V., Schuster, T., Kotzsch, M., Kiechle, M. B., Meindl, A., Sweep, F. C. G. J., Span, P. N., & Groß, E. (2013) · PLoS ONE · doi:10.1371/journal.pone.0060359 · Cited by 44
Cited by
Blood-Brain Barrier: From Physiology to Disease and Back
Sweeney, M. D., Zhao, Z., Montagne, A., Nelson, A. R., & Zlokovic, B. V. (2019) · Physiological Reviews · doi:10.1152/physrev.00050.2017 · Cited by 2,312
Dichgans, M., & Leys, D. (2017) · Circulation Research · doi:10.1161/circresaha.116.308426 · Cited by 581
Self-citationVascular Cognitive Impairment (VCI)
Rundek, T., Tolea, M., Ariko, T., Fagerli, E. A., & Camargo, C. J. (2022) · Neurotherapeutics · doi:10.1007/s13311-021-01170-y · Cited by 305
Traylor, M., Persyn, E., Tomppo, L., Klasson, S., Abedi, V., Bakker, M. K., Torres, N., Li, L., Bell, S., Rutten-Jacobs, L., et al. (2021) · The Lancet Neurology · doi:10.1016/s1474-4422(21)00031-4 · Cited by 213
Self-citationHeterozygous HTRA1 mutations are associated with autosomal dominant cerebral small vessel disease
Verdura, E., Hervé, D., Scharrer, E., Amador, M. D. M., Guyant-Maréchal, L., Philippi, A., Corlobé, A., Bergametti, F., Gazal, S., Prieto-Morin, C., et al. (2015) · Brain · doi:10.1093/brain/awv155 · Cited by 200
Self-citation
Metadata
- Authors
- Beaufort, N., Scharrer, E., Kremmer, E., Lux, V., Ehrmann, M., Huber, R., Houlden, H., Werring, D., Haffner, C., & Dichgans, M.
- Affiliations
- LMU Klinikum (DE)
- Helmholtz Munich (DE)
- University of Duisburg-Essen (DE)
- Center for Integrated Protein Science Munich (DE)
- National Hospital for Neurology and Neurosurgery (GB)
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2014-11-04
- Volume
- 111
- Issue
- 46
- Pages
- 16496-16501
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC4246310
- OpenAlex
- W2066261285
- Cited by
- 145
- References
- 40
- Citations by year
- 2026: 4 · 2025: 11 · 2024: 17 · 2023: 8 · 2022: 10 · 2021: 20 · 2020: 18 · 2019: 12 · 2018: 16 · 2017: 16 · 2016: 4 · 2015: 8
- FWCI
- 3.82
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- ORCA Online Research @Cardiff (Cardiff University) (submittedVersion)
- Site cant be reached (submittedVersion)
- Funders
- Medical Research Council (MR/J004758/1)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Health Sciences › Medicine › Clinical Neurology › Cerebrovascular and genetic disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Protease and Inhibitor Mechanisms
- Keywords
- HTRA1, serine protease, latent TGF-beta binding protein-1, TGF-beta signaling, CARASIL, cerebral small vessel disease, extracellular matrix, fibronectin, proteolytic processing, stroke in young adults
- MeSH terms
- High-Temperature Requirement A Serine Peptidase 1, Alopecia, Animals, Brain, Cells, Cultured, Cerebral Infarction, Fibroblasts, Fibronectins, Gene Expression Regulation, Humans, Protein Binding, Protein Processing, Post-Translational, Recombinant Fusion Proteins, RNA, Messenger, Serine Endopeptidases, Skin, Spinal Diseases, Transfection, Signal Transduction, Point Mutation, Mice, Knockout, Mutation, Missense, Protein Interaction Mapping, Mice, Transforming Growth Factor beta1, Latent TGF-beta Binding Proteins, Connective Tissue Growth Factor, Leukoencephalopathies, HEK293 Cells, Serpin E2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.